Cyclic AMP regulates the HERG K(+) channel by dual pathways

Area of Science:

• Cardiovascular Physiology
• Molecular Biology
• Genetics

Background:

• Hereditary Long QT syndrome (LQTS) is characterized by lethal cardiac arrhythmias.
• These arrhythmias are often stress-induced, implicating beta-adrenergic signaling and cyclic AMP (cAMP).
• Second messengers like cAMP modulate ion channel activity through direct interaction or kinase/phosphatase pathways.

Purpose of the Study:

• To investigate the regulation of the HERG potassium channel, mutated in LQT2, by the second messenger cAMP.
• To elucidate the direct and indirect mechanisms by which cAMP affects HERG channel function.

Main Methods:

• Investigated the effects of cAMP-dependent protein kinase (PKA) activation on HERG channel phosphorylation and function.
• Examined the direct binding of cAMP to the HERG protein.
• Assessed the impact of HERG complexation with MiRP1 or minK on cAMP-mediated regulation.

Main Results:

• PKA activation phosphorylates HERG, reducing current amplitude and altering voltage-dependent gating.
• cAMP directly binds to HERG, causing a shift in voltage-dependent activation.
• Complexation with MiRP1 or minK favors stimulatory cAMP effects on HERG.
• The net effect of cAMP is a diminution of HERG current, but this is modulated by accessory proteins.

Conclusions:

• cAMP uniquely regulates the LQT2-associated HERG channel via parallel direct and indirect pathways.
• This dual regulation provides a direct molecular link between stress, beta-adrenergic activation, and cardiac arrhythmias in LQTS.
• The interaction with accessory proteins like MiRP1 and minK modifies the channel's response to cAMP, influencing arrhythmogenesis.